Han Ying
Hoofd Techniek/Wetenschap/O&O bij IMMUNOTECH BIOPHARM LTD
Profiel
Han Ying is the founder of Gene Corp., which was founded in 2021.
Dr. Ying is currently the Chief Executive Officer & Director at Gyre Therapeutics, Inc. since 2023 and the Chief Scientific Officer at Immunotech Biopharm Ltd.
Dr. Ying previously worked as a Director at Base Therapeutics.
Dr. Ying obtained a doctorate degree from Stanford University and completed undergraduate and graduate degrees from Peking University.
Actieve functies van Han Ying
| Bedrijven | Functie | Begin |
|---|---|---|
| IMMUNOTECH BIOPHARM LTD | Hoofd Techniek/Wetenschap/O&O | - |
Eerdere bekende functies van Han Ying
| Bedrijven | Functie | Einde |
|---|---|---|
Gene Corp.
 Gene Corp. Specialty StoresRetail Trade Part of East Japan Railway Co., Gene Corp. operates sundry goods stores. The company is based in Setagaya-ku, Japan. Gene was acquired by Lumine Co., Ltd. on September 07, 2004. | Oprichter | - |
Opleiding van Han Ying
| Stanford University | Doctorate Degree |
| Peking University | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| IMMUNOTECH BIOPHARM LTD | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Gene Corp.
Gene Corp. Specialty StoresRetail Trade Part of East Japan Railway Co., Gene Corp. operates sundry goods stores. The company is based in Setagaya-ku, Japan. Gene was acquired by Lumine Co., Ltd. on September 07, 2004. | Retail Trade |
